Screener
Agios Pharmaceuticals AGIO Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
| (In thousands) | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net cash provided by financing activities | 5,227 | 1,684 |
| Net change in cash and cash equivalents | 10,517 | 4,624 |
| Cash and cash equivalents at beginning of the period | 89,130 | 76,247 |
| Cash and cash equivalents at end of the period | $99,647 | $80,871 |
| Supplemental disclosure of non-cash investing and financing transactions | ||
| Additions to property and equipment in accounts payable | $186 | $122 |
| Exchanges of marketable securities | $2,229 | — |
| Net cash taxes paid | $74 | $1,503 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Agios Pharmaceuticals's cash & equivalents?
- Agios Pharmaceuticals (AGIO) reported cash & equivalents of $99.65M in Q2 2026.
- How has Agios Pharmaceuticals's cash & equivalents changed year-over-year?
- Agios Pharmaceuticals's cash & equivalents increased by 23.2% year-over-year, from $80.87M to $99.65M.
- What is the long-term trend for Agios Pharmaceuticals's cash & equivalents?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's cash & equivalents has grown at a -6.9% compound annual growth rate (CAGR), from $127.44M to $89.13M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Agios Pharmaceuticals's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude